180 related articles for article (PubMed ID: 20532456)
21. QRS-based assessment of myocardial damage and adverse events associated with cardiac sarcoidosis.
Sobue Y; Harada M; Koshikawa M; Ichikawa T; Yamamoto M; Okuda K; Kato Y; Sarai M; Watanabe E; Ozaki Y
Heart Rhythm; 2015 Dec; 12(12):2499-507. PubMed ID: 26362576
[TBL] [Abstract][Full Text] [Related]
22. Cardiac sarcoidosis presenting as arrhythmogenic right ventricular cardiomyopathy/dysplasia with ventricular aneurysms: a case report.
Petrovic M; Buja LM; Kar B; Colnaric J; Damaraju S; Zhao B; Akkanti B; Radovanovic M; Radovancevic R; Loyalka P; Gregoric ID
Cardiovasc Pathol; 2018; 33():1-5. PubMed ID: 29245138
[TBL] [Abstract][Full Text] [Related]
23. Undiagnosed Cardiac Sarcoidosis Causing Refractory Heart Failure After Acute Myocardial Infarction due to Thromboembolism.
Kai T; Ono Y; Matsushima S; Shinohara K; Nakashima R; Kawahara T; Katsuki M; Fujino T; Hashimoto T; Higo T; Tsutsui H
Int Heart J; 2021 Mar; 62(2):437-440. PubMed ID: 33731532
[TBL] [Abstract][Full Text] [Related]
24. Demonstration of cardiac involvement of sarcoidosis by contrast-enhanced multislice computed tomography and delayed-enhanced magnetic resonance imaging.
Kanao S; Tadamura E; Yamamuro M; Kubo S; Kimura T; Kita T; Togashi K
J Comput Assist Tomogr; 2005; 29(6):745-8. PubMed ID: 16272844
[TBL] [Abstract][Full Text] [Related]
25. Atrioventricular block as the initial manifestation of cardiac sarcoidosis in middle-aged adults.
Nery PB; Beanlands RS; Nair GM; Green M; Yang J; McArdle BA; Davis D; Ohira H; Gollob MH; Leung E; Healey JS; Birnie DH
J Cardiovasc Electrophysiol; 2014 Aug; 25(8):875-881. PubMed ID: 24602015
[TBL] [Abstract][Full Text] [Related]
26. Late gadolinium enhancement in cardiac sarcoidosis: characteristic magnetic resonance findings and relationship with left ventricular function.
Watanabe E; Kimura F; Nakajima T; Hiroe M; Kasai Y; Nagata M; Kawana M; Hagiwara N
J Thorac Imaging; 2013 Jan; 28(1):60-6. PubMed ID: 23249970
[TBL] [Abstract][Full Text] [Related]
27. Cardiac sarcoidosis evaluated with gadolinium-enhanced magnetic resonance and contrast-enhanced 64-slice computed tomography.
Smedema JP; Truter R; de Klerk PA; Zaaiman L; White L; Doubell AF
Int J Cardiol; 2006 Sep; 112(2):261-3. PubMed ID: 16257460
[TBL] [Abstract][Full Text] [Related]
28. Diagnosis of cardiac sarcoidosis and evaluation of the effects of steroid therapy by gadolinium-DTPA-enhanced magnetic resonance imaging.
Shimada T; Shimada K; Sakane T; Ochiai K; Tsukihashi H; Fukui M; Inoue S; Katoh H; Murakami Y; Ishibashi Y; Maruyama R
Am J Med; 2001 May; 110(7):520-7. PubMed ID: 11343665
[TBL] [Abstract][Full Text] [Related]
29. Visualization of cardiac involvement in patients with systemic sarcoidosis applying contrast-enhanced magnetic resonance imaging.
Schulz-Menger J; Strohm O; Dietz R; Friedrich MG
MAGMA; 2000 Nov; 11(1-2):82-3. PubMed ID: 11186999
[TBL] [Abstract][Full Text] [Related]
30. Late gadolinium enhancement identified with cardiac magnetic resonance imaging in sarcoidosis patients is associated with long-term ventricular arrhythmia and sudden cardiac death.
Nadel J; Lancefield T; Voskoboinik A; Taylor AJ
Eur Heart J Cardiovasc Imaging; 2015 Jun; 16(6):634-41. PubMed ID: 25617029
[TBL] [Abstract][Full Text] [Related]
31. Cardiac Magnetic Resonance Imaging-Based Screening for Cardiac Sarcoidosis in Patients With Atrioventricular Block Requiring Temporary Pacing.
Vuorinen AM; Lehtonen J; Pakarinen S; Holmström M; Kivistö S; Kaasalainen T
J Am Heart Assoc; 2022 Jun; 11(11):e024257. PubMed ID: 35658507
[TBL] [Abstract][Full Text] [Related]
32. [Cardiac sarcoidosis].
Chapelon-Abric C
Ann Med Interne (Paris); 2001 Mar; 152(2):125-33. PubMed ID: 11357049
[TBL] [Abstract][Full Text] [Related]
33. The work-up and management of patients with apparent or subclinical cardiac sarcoidosis: with emphasis on the associated heart rhythm abnormalities.
Soejima K; Yada H
J Cardiovasc Electrophysiol; 2009 May; 20(5):578-83. PubMed ID: 19175448
[TBL] [Abstract][Full Text] [Related]
34. Second left ventricular aneurysm newly developed in a patient with untreated cardiac sarcoidosis.
Sato T; Kanzaki H; Ishida Y; Amaki M; Ohara T; Hasegawa T; Hashimura K; Nakatani S; Yamada N; Ikeda Y; Ueda-Ishibashi H; Kitakaze M
Circ J; 2010 Nov; 74(11):2477-8. PubMed ID: 20890051
[No Abstract] [Full Text] [Related]
35. [Diagnosis of isolated cardiac sarcoidosis].
Trisvetova EL; Yudina OA; Smolensky AZ; Cherstvyi ED
Arkh Patol; 2019; 81(1):57-64. PubMed ID: 30830107
[TBL] [Abstract][Full Text] [Related]
36. Presence of Late Gadolinium Enhancement by Cardiac Magnetic Resonance Among Patients With Suspected Cardiac Sarcoidosis Is Associated With Adverse Cardiovascular Prognosis: A Systematic Review and Meta-Analysis.
Hulten E; Agarwal V; Cahill M; Cole G; Vita T; Parrish S; Bittencourt MS; Murthy VL; Kwong R; Di Carli MF; Blankstein R
Circ Cardiovasc Imaging; 2016 Sep; 9(9):e005001. PubMed ID: 27621357
[TBL] [Abstract][Full Text] [Related]
37. High mass (>18g) of late gadolinium enhancement on CMR imaging is associated with major cardiac events on long-term outcome in patients with biopsy-proven extracardiac sarcoidosis.
Agoston-Coldea L; Kouaho S; Sacre K; Dossier A; Escoubet B; Chillon S; Laissy JP; Rouzet F; Kutty S; Extramiana F; Leenhardt A; Borie R; Crestani B; Ou P
Int J Cardiol; 2016 Nov; 222():950-956. PubMed ID: 27526366
[TBL] [Abstract][Full Text] [Related]
38. Assessment of the 2017 AHA/ACC/HRS Guideline Recommendations for Implantable Cardioverter-Defibrillator Implantation in Cardiac Sarcoidosis.
Kazmirczak F; Chen KA; Adabag S; von Wald L; Roukoz H; Benditt DG; Okasha O; Farzaneh-Far A; Markowitz J; Nijjar PS; Velangi PS; Bhargava M; Perlman D; Duval S; Akçakaya M; Shenoy C
Circ Arrhythm Electrophysiol; 2019 Sep; 12(9):e007488. PubMed ID: 31431050
[TBL] [Abstract][Full Text] [Related]
39. [MRI in cardiac sarcoidosis and amyloidosis].
Bauner KU; Wintersperger B
Radiologe; 2013 Jan; 53(1):54-60. PubMed ID: 23242036
[TBL] [Abstract][Full Text] [Related]
40. Extensive late gadolinium enhancement on cardiovascular magnetic resonance predicts adverse outcomes and lack of improvement in LV function after steroid therapy in cardiac sarcoidosis.
Ise T; Hasegawa T; Morita Y; Yamada N; Funada A; Takahama H; Amaki M; Kanzaki H; Okamura H; Kamakura S; Shimizu W; Anzai T; Kitakaze M
Heart; 2014 Aug; 100(15):1165-72. PubMed ID: 24829369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
